4.6 Article

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat

Yuki Matsushita et al.

Summary: Metabolic reprogramming is a key feature of cancer, where changes in lipid metabolism are now recognized to play an important role in cancer biology. Recent advancements in lipidomics technologies have provided insights into the roles of lipids in cancer, impacting cellular functions and contributing to carcinogenesis. The interaction between cancer cells and the surrounding microenvironment through altered lipid metabolism supports tumor growth and progression, highlighting the potential for novel metabolic targets in cancer treatment.

CANCERS (2021)

Article Biochemical Research Methods

Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics

Lenka Michalkova et al.

Summary: Through H-1 NMR metabolomic analysis, the association between pancreatic cancer and type 2 diabetes mellitus was identified, leading to the establishment and testing of a panel of metabolites for disease identification. A prediction model was also developed and tested on recent-onset diabetes mellitus patients, showing potential for identifying individuals at risk for developing pancreatic cancer.

JOURNAL OF PROTEOME RESEARCH (2021)

Article Oncology

Metabolomics in cancer research and emerging applications in clinical oncology

Daniel R. Schmidt et al.

Summary: Cancer has complex effects on cellular and systemic metabolism, with metabolomics playing a crucial role in providing insights for cancer diagnosis, monitoring, and therapy. Advances in technology have expanded the applications of metabolomics in clinical research, with the potential to further enhance cancer patient management in the future.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development

Xiaoye Duan et al.

Summary: The relationship between T2DM and PC is complex, with new-onset diabetes possibly serving as an early warning sign for PC. Metformin shows benefits in inhibiting PC, while insulin therapy may increase the risk of PC development. Novel hypoglycemic drugs have not shown clear effects on PC prevention.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma

Sumit Sahni et al.

Summary: The study identified a six-metabolite panel from urine samples with high potential for detecting and diagnosing pancreatic ductal adenocarcinoma (PDAC). This panel also showed strong potential for early detection of PDAC, paving the way for the development of a urine-based detection method in the future.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, General & Internal

A Screening Test for Early Diagnosis of Microcellular Bronchopulmonary Cancer-Pilot Study

Claudiu-Eduard Nistor et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Biochemical Research Methods

Enantioanalysis of glutamine-a key factor in establishing the metabolomics process in gastric cancer

Raluca-Ioana Stefan-van Staden et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2020)

Article Oncology

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

Ariadna Martin-Blazquez et al.

CANCERS (2020)

Review Medical Laboratory Technology

OMICS insights into cancer histology; Metabolomics and proteomics approach

Akram Tayanloo-Beik et al.

CLINICAL BIOCHEMISTRY (2020)

Review Cell Biology

The Janus-like role of proline metabolism in cancer

Lynsey Burke et al.

CELL DEATH DISCOVERY (2020)

Review Oncology

Optimizing the outcomes of pancreatic cancer surgery

Oliver Strobel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Applications of metabolomics to study cancer metabolism

Akash K. Kaushik et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Article Multidisciplinary Sciences

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

Orianne Olivares et al.

NATURE COMMUNICATIONS (2017)

Review Oncology

Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer

Christopher J. Habrook et al.

CANCER CELL (2017)

Review Oncology

Metabolomics in pancreatic cancer biomarkers research

Jaroslav Tumas et al.

MEDICAL ONCOLOGY (2016)

Review Cell Biology

Metabolomics: beyond biomarkers and towards mechanisms

Caroline H. Johnson et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Structured Reporting of Multiphasic CT for Pancreatic Cancer: Potential Effect on Staging and Surgical Planning

Olga R. Brook et al.

RADIOLOGY (2015)

Article Gastroenterology & Hepatology

Early events in pancreatic cancer

Isobel Leake

Nature Reviews Gastroenterology & Hepatology (2014)

Review Immunology

Amino Acid Metabolism Related to Immune Tolerance by MDSCs

Baohong Yang et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)

Article Oncology

Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics

Oliver F. Bathe et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)

Review Oncology

Plasma free amino acid profile in cancer patients

HS Lai et al.

SEMINARS IN CANCER BIOLOGY (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

Detection of small pancreatic tumors with multiphasic helical CT

YL Bronstein et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2004)